Ultragenyx Pharmaceutical Inc. SEC filings RARE
Ultragenyx Pharmaceutical Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Jul 20, 2015. Its latest annual report, Form ARS, was filed on Mar 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (acquisition or sale of assets, results of operations, exit or restructuring costs). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Jun 12, 2026 | — |
| S-8 | Employee stock plan registration | Jul 18, 2025 | — |
| S-8 | Employee stock plan registration | Jul 12, 2024 | — |
| 424B5 | Prospectus supplement | Jun 14, 2024 | — |
| 424B5 | Prospectus supplement | Jun 12, 2024 | — |
| S-3ASR | Automatic shelf registration | Feb 21, 2024 | — |
| 424B5 | Prospectus supplement | Oct 20, 2023 | — |
| FWP | Free writing prospectus | Oct 19, 2023 | — |
| 424B5 | Prospectus supplement | Oct 17, 2023 | — |
| S-8 | Employee stock plan registration | Jun 8, 2023 | — |
| S-8 | Employee stock plan registration | Feb 17, 2023 | — |
| S-8 | Employee stock plan registration | Feb 15, 2022 | — |
| 424B5 | Prospectus supplement | May 7, 2021 | — |
| S-3ASR | Automatic shelf registration | Feb 12, 2021 | — |
| S-8 | Employee stock plan registration | Feb 12, 2021 | — |
| 424B5 | Prospectus supplement | Oct 29, 2020 | — |
| 424B5 | Prospectus supplement | Oct 28, 2020 | — |
| S-8 | Employee stock plan registration | Feb 14, 2020 | — |
| 424B5 | Prospectus supplement | Feb 27, 2019 | — |
| 424B5 | Prospectus supplement | Feb 25, 2019 | — |
| S-8 | Employee stock plan registration | Feb 20, 2019 | — |
| 424B5 | Prospectus supplement | Mar 30, 2018 | — |
| S-8 | Employee stock plan registration | Feb 21, 2018 | — |
| S-3ASR | Automatic shelf registration | Feb 21, 2018 | — |
| 424B5 | Prospectus supplement | Jan 24, 2018 | — |
| 424B5 | Prospectus supplement | Jan 23, 2018 | — |
| S-8 | Employee stock plan registration | Nov 7, 2017 | — |
| 424B5 | Prospectus supplement | Jul 28, 2017 | — |
| S-8 | Employee stock plan registration | Feb 17, 2017 | — |
| 424B7 | Filing | Dec 2, 2016 | — |
| 424B7 | Filing | Aug 10, 2016 | — |
| 424B5 | Prospectus supplement | Jul 1, 2016 | — |
| S-8 | Employee stock plan registration | Feb 26, 2016 | — |
Showing 33 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RARE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Novato, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1515673
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.